Olema Pharmaceuticals, Inc. (OLMA) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ian T Clark

Director

—

$7.87M (3) scheduled

−$7.87M

0

0.0000%

$0.00

—

Naseem Zojwalla

Chief Medical Officer

—

$7.53M (4) scheduled

−$7.53M

4,488

0.0051%

$52.57K

−95.3%

David C. Myles

Ch. Discov. & Non-Clin Dev Off

—

$4.66M (8) scheduled

−$4.66M

687,607

0.7859%

$8.05M

−6.4%

Shane William Charles Kovacs

Ch. Operating & Financial Off.

—

$2.98M (2)

−$2.98M

139,727

0.1597%

$1.64M

−71.2%

Shawnte Mitchell

Chief Legal Officer

—

$951.50K (3) scheduled

−$951.50K

0

0.0000%

$0.00

—

Cyrus Harmon

Director

—

$743.76K (5)

−$743.76K

819,798

0.9369%

$9.60M

−6.1%

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

4,300,000

4.91%

$50.37M

−42.7%

G. Walmsley Graham

Director

—

1,408,875

1.61%

$16.50M

−49.9%

Bvf Partners L P/Il entity

Director

—

347,970

0.3977%

$4.08M

−91.6%

Sean Bohen

President and CEO

—

237,650

0.2716%

$2.78M

+57.5%

Sasha Lu Austin

VP of Finance and Controller

—

16,188

0.0185%

$189.63K

+260.7%

Andrew Rappaport

Director

—

0

0.0000%

$0.00

—

Olema Pharmaceuticals, Inc.

What the insiders did Net selling

By person